Expired Canadian patentCanada
Humanized antibodies that recognize beta amyloid peptide
CA 2525975 C · Owner: Bard, Frederique · Inventors: Basi, Guriq; Bard, Frederique; Saldanha, Jose William
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides improved agents and methods for treatment of diseases associated with amyloid deposits of A.szlig. in the brain of a patient. Preferred agents include antibodies, e.g. humanized antibodies.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 1, 2004 and granted September 23, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 1, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 1, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 1, 2004
GrantedSeptember 23, 2014
Term endedJune 1, 2024
Patent numberCA 2525975 C
Classification (IPC)C07K16/00 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.